Brief: Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results And Provides Business Update
09/03/2023 13:08
March 9 (Reuters) - Prime Medicine Inc PRME.O :
* PRIME MEDICINE REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
* PRIME MEDICINE INC - AS OF DECEMBER 31, 2022, CASH,
SHORT-TERM
INVESTMENTS AND RELATED PARTY SHORT TERM INVESTMENTS WERE $293.9
MILLION
* PRIME MEDICINE INC - CASH, CASH EQUIVALENTS, SHORT-TERM
INVESTMENTS AS OF DEC 31, TO FUND OPERATING EXPENSES & CAP EX
REQUIREMENTS INTO 2025
* PRIME MEDICINE INC- QTRLY LOSS PER SHARE $0.56
Source text for Eikon: ID:nGNX3BDqdS
Further company coverage: PRME.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease